239 related articles for article (PubMed ID: 32710698)
1. Prolongation of radiotherapy duration is associated with inferior overall survival in patients with pediatric medulloblastoma and central nervous system primitive neuroectodermal tumors.
Baliga S; Bajaj BVM; Kabarriti R; Grassberger C; Patteson B; Yeap B; Fox JL; Garg MK; Yock TI
Pediatr Blood Cancer; 2020 Oct; 67(10):e28558. PubMed ID: 32710698
[TBL] [Abstract][Full Text] [Related]
2. A phase II study of preradiotherapy chemotherapy followed by hyperfractionated radiotherapy for newly diagnosed high-risk medulloblastoma/primitive neuroectodermal tumor: a report from the Children's Oncology Group (CCG 9931).
Allen J; Donahue B; Mehta M; Miller DC; Rorke LB; Jakacki R; Robertson P; Sposto R; Holmes E; Vezina G; Muraszko K; Puccetti D; Prados M; Chan KW
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1006-11. PubMed ID: 19356859
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant chemotherapy and overall survival in adult medulloblastoma.
Kann BH; Lester-Coll NH; Park HS; Yeboa DN; Kelly JR; Baehring JM; Becker KP; Yu JB; Bindra RS; Roberts KB
Neuro Oncol; 2017 Feb; 19(2):259-269. PubMed ID: 27540083
[TBL] [Abstract][Full Text] [Related]
4. Outcome for children treated for medulloblastoma and supratentorial primitive neuroectodermal tumor (CNS-PNET) - a retrospective analysis spanning 40 years of treatment.
Stensvold E; Krossnes BK; Lundar T; Due-Tønnessen BJ; Frič R; Due-Tønnessen P; Bechensteen AG; Myklebust TÅ; Johannesen TB; Brandal P
Acta Oncol; 2017 May; 56(5):698-705. PubMed ID: 28325133
[TBL] [Abstract][Full Text] [Related]
5. Is there an increased risk of spinal relapse in standard-risk medulloblastoma/primitive neuroectodermal tumor patients who receive only a reduced dose of craniospinal radiotherapy?
Burcu A; Nazan Ç; Özgür Ö; Serra K; Mehmet K; Serap A; Bengü D; Canan V; Haldun Ö; Savaş K; Tuncer T; Taner A; Yeşim E; Ömer K; Yavuz A
Childs Nerv Syst; 2018 Sep; 34(9):1657-1662. PubMed ID: 29868932
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of intracranial cerebrospinal fluid cytology in staging pediatric medulloblastomas, supratentorial primitive neuroectodermal tumors, and ependymomas.
Terterov S; Krieger MD; Bowen I; McComb JG
J Neurosurg Pediatr; 2010 Aug; 6(2):131-6. PubMed ID: 20672933
[TBL] [Abstract][Full Text] [Related]
7. Survival impact of postoperative radiotherapy timing in pediatric and adolescent medulloblastoma.
Chin AL; Moding EJ; Donaldson SS; Gibbs IC; Soltys SG; Hiniker SM; Pollom EL
Neuro Oncol; 2018 Jul; 20(8):1133-1141. PubMed ID: 29309676
[TBL] [Abstract][Full Text] [Related]
8. Children treated for medulloblastoma and supratentorial primitive neuroectodermal tumor in Norway from 1974 through 2013: Unexplainable regional differences in survival.
Stensvold E; Myklebust TÅ; Cappelen J; Due-Tønnessen BJ; Due-Tønnessen P; Kepka A; Johannesen TB; Krossnes B; Lundar T; Maric S; Miletic H; Moholdt V; Myrmel KS; Nordberg T; Rydland J; Stokland T; Solem K; Solheim O; Torsvik I; Wikran GC; Zeller B; Wesenberg F; Bechensteen AG; Brandal P
Pediatr Blood Cancer; 2019 Oct; 66(10):e27910. PubMed ID: 31264356
[TBL] [Abstract][Full Text] [Related]
9. Reduced-volume tumor-bed boost is not associated with inferior local control and survival outcomes in high-risk medulloblastoma.
Tian S; Sudmeier LJ; Zhang C; Madden NA; Buchwald ZS; Shu HG; Curran WJ; Eaton BR; Esiashvili N
Pediatr Blood Cancer; 2020 Jan; 67(1):e28027. PubMed ID: 31571408
[TBL] [Abstract][Full Text] [Related]
10. Hyperfractionated craniospinal radiotherapy and adjuvant chemotherapy for children with newly diagnosed medulloblastoma and other primitive neuroectodermal tumors.
Allen JC; Donahue B; DaRosso R; Nirenberg A
Int J Radiat Oncol Biol Phys; 1996 Dec; 36(5):1155-61. PubMed ID: 8985038
[TBL] [Abstract][Full Text] [Related]
11. Radiosurgery or hypofractionated stereotactic radiotherapy after craniospinal irradiation in children and adults with medulloblastoma and ependymoma.
Napieralska A; Brąclik I; Radwan M; Mandera M; Blamek S
Childs Nerv Syst; 2019 Feb; 35(2):267-275. PubMed ID: 30515559
[TBL] [Abstract][Full Text] [Related]
12. Radiotherapy for pediatric central nervous system tumors: a regional cancer centre experience.
Bauman G; Fisher B; Cairney E; Ranger A; Dar AR; Ross J; Stitt L; MacDonald D
J Neurooncol; 2004 Jul; 68(3):285-94. PubMed ID: 15332333
[TBL] [Abstract][Full Text] [Related]
13. Proton radiation therapy for pediatric medulloblastoma and supratentorial primitive neuroectodermal tumors: outcomes for very young children treated with upfront chemotherapy.
Jimenez RB; Sethi R; Depauw N; Pulsifer MB; Adams J; McBride SM; Ebb D; Fullerton BC; Tarbell NJ; Yock TI; Macdonald SM
Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):120-6. PubMed ID: 23790826
[TBL] [Abstract][Full Text] [Related]
14. Promising survival rate but high incidence of treatment-related mortality after reduced-dose craniospinal radiotherapy and tandem high-dose chemotherapy in patients with high-risk medulloblastoma.
Lee JW; Lim DH; Sung KW; Cho HW; Ju HY; Hyun JK; Yoo KH; Koo HH; Suh YL; Joung YS; Shin HJ
Cancer Med; 2020 Aug; 9(16):5807-5818. PubMed ID: 32608158
[TBL] [Abstract][Full Text] [Related]
15. [Current and future strategies in interdisciplinary treatment of medulloblastomas, supratentorial PNET (primitive neuroectodermal tumors) and intracranial germ cell tumors in childhood].
Kortmann RD; Kühl J; Timmermann B; Calaminus G; Dieckmann K; Wurm R; Sörensen N; Urban C; Göbel U; Bamberg M
Strahlenther Onkol; 2001 Sep; 177(9):447-61. PubMed ID: 11591018
[TBL] [Abstract][Full Text] [Related]
16. Treatment of high-risk medulloblastoma and other primitive neuroectodermal tumors with reduced dose craniospinal radiation therapy and multi-agent nitrosourea-based chemotherapy.
Prados MD; Wara W; Edwards MS; Ater J; Rabbit J; Lamborn K; Davis R; Levin VA
Pediatr Neurosurg; 1996 Oct; 25(4):174-81. PubMed ID: 9293544
[TBL] [Abstract][Full Text] [Related]
17. High-dose chemotherapy and autologous stem cell rescue in children with newly diagnosed high-risk or relapsed medulloblastoma or supratentorial primitive neuroectodermal tumor.
Sung KW; Yoo KH; Cho EJ; Koo HH; Lim DH; Shin HJ; Ahn SD; Ra YS; Choi ES; Ghim TT
Pediatr Blood Cancer; 2007 Apr; 48(4):408-15. PubMed ID: 17066462
[TBL] [Abstract][Full Text] [Related]
18. Phase II study of temozolomide and topotecan (TOTEM) in children with relapsed or refractory extracranial and central nervous system tumors including medulloblastoma with post hoc Bayesian analysis: A European ITCC study.
Le Teuff G; Castaneda-Heredia A; Dufour C; Jaspan T; Calmon R; Devos A; McHugh K; Leblond P; Frappaz D; Aerts I; Zwaan CM; Ducassou S; Chastagner P; Verschuur A; Corradini N; Casanova M; Rubie H; Riccardi R; Le Deley MC; Vassal G; Geoerger B;
Pediatr Blood Cancer; 2020 Jan; 67(1):e28032. PubMed ID: 31595663
[TBL] [Abstract][Full Text] [Related]
19. Relapse patterns in pediatric embryonal central nervous system tumors.
Perreault S; Lober RM; Carret AS; Zhang G; Hershon L; Décarie JC; Yeom K; Vogel H; Fisher PG; Partap S
J Neurooncol; 2013 Nov; 115(2):209-15. PubMed ID: 23921420
[TBL] [Abstract][Full Text] [Related]
20. Clinical Outcomes Among Children With Standard-Risk Medulloblastoma Treated With Proton and Photon Radiation Therapy: A Comparison of Disease Control and Overall Survival.
Eaton BR; Esiashvili N; Kim S; Weyman EA; Thornton LT; Mazewski C; MacDonald T; Ebb D; MacDonald SM; Tarbell NJ; Yock TI
Int J Radiat Oncol Biol Phys; 2016 Jan; 94(1):133-138. PubMed ID: 26700707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
